Equillium Reports $5.31M Net Loss for First Quarter
EQ has more than doubled off its 52-week low of $0.27.
Summary
Equillium, Inc. announced a net loss of $5.31 million for the first quarter. While the headline provides a key financial figure, it lacks additional context such as revenue, earnings per share, or comparison to analyst expectations. This quarterly loss is a material financial update for the company. It follows recent successful equity financings of $65 million in August 2025 and March 2026, which were projected to fund operations into 2029. Traders will be looking for the full earnings report to assess the company's cash burn rate and operational performance in light of its current funding.
At the time of this announcement, EQ was trading at $2.31 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $146.1M. The 52-week trading range was $0.27 to $2.70. This news item was assessed with negative market sentiment and an importance score of 7 out of 10. Source: Dow Jones Newswires.